Phathom Pharmaceuticals, Inc. PHAT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s operating cash flow?
- Phathom Pharmaceuticals, Inc. (PHAT) reported operating cash flow of -$15.65M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s operating cash flow increased by 81.6% year-over-year, from -$84.93M to -$15.65M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s operating cash flow has grown at a 3.0% compound annual growth rate (CAGR), from -$148.46M to -$166.78M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.